Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus
- PMID: 17719070
- DOI: 10.1016/j.virol.2007.05.042
Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus
Abstract
The surface of the mature dengue virus (DENV) particle consists of 90 envelope (E) protein dimers that mediate both receptor binding and fusion. The E protein ectodomain can be divided into three structural domains designated ED1, ED2, and ED3, of which ED3 contains the critical and dominant virus-specific neutralization sites. In this study the ED3 epitopes recognized by seven, murine, IgG1 DENV-2 type-specific, monoclonal antibodies (MAbs) were determined using site-directed mutagenesis of a recombinant DENV-2 ED3 (rED3) protein. A total of 41 single amino acid substitutions were introduced into the rED3 at 30 different surface accessible residues. The affinity of each MAb with the mutant rED3s was assessed by indirect ELISA and the results indicate that all seven MAbs recognize overlapping epitopes with residues K305 and P384 critical for binding. These residues are conserved among DENV-2 strains and cluster together on the upper lateral face of ED3. A linear relationship was observed between relative occupancy of ED3 on the virion by MAb and neutralization of the majority of virus infectivity ( approximately 90%) for all seven MAbs. Depending on the MAb, it is predicted that between 10% and 50% relative occupancy of ED3 on the virion is necessary for virus neutralization and for all seven MAbs occupancy levels approaching saturation were required for 100% neutralization of virus infectivity. Overall, the conserved antigenic site recognized by all seven MAbs is likely to be a dominant DENV-2 type-specific, neutralization determinant.
Similar articles
-
Characterization of dengue complex-reactive epitopes on dengue 3 virus envelope protein domain III.Virology. 2009 Feb 5;384(1):16-20. doi: 10.1016/j.virol.2008.11.013. Epub 2008 Dec 19. Virology. 2009. PMID: 19101005
-
Characterization of dengue virus complex-specific neutralizing epitopes on envelope protein domain III of dengue 2 virus.J Virol. 2008 Sep;82(17):8828-37. doi: 10.1128/JVI.00606-08. Epub 2008 Jun 18. J Virol. 2008. PMID: 18562544 Free PMC article.
-
Mutations of an antibody binding energy hot spot on domain III of the dengue 2 envelope glycoprotein exploited for neutralization escape.Virology. 2010 Nov 25;407(2):237-46. doi: 10.1016/j.virol.2010.06.044. Epub 2010 Sep 15. Virology. 2010. PMID: 20832836
-
GP4-specific neutralizing antibodies might be a driving force in PRRSV evolution.Virus Res. 2010 Dec;154(1-2):104-13. doi: 10.1016/j.virusres.2010.08.026. Epub 2010 Sep 15. Virus Res. 2010. PMID: 20837070 Review.
-
Fab'-induced folding of antigenic N-terminal peptides from intrinsically disordered HIV-1 Tat revealed by X-ray crystallography.J Mol Biol. 2011 Jan 7;405(1):33-42. doi: 10.1016/j.jmb.2010.10.033. Epub 2010 Oct 28. J Mol Biol. 2011. PMID: 21035463 Review.
Cited by
-
Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions.Proc Natl Acad Sci U S A. 2012 May 8;109(19):7439-44. doi: 10.1073/pnas.1200566109. Epub 2012 Apr 12. Proc Natl Acad Sci U S A. 2012. PMID: 22499787 Free PMC article.
-
Analysis of cross-reactive antibodies recognizing the fusion loop of envelope protein and correlation with neutralizing antibody titers in Nicaraguan dengue cases.PLoS Negl Trop Dis. 2013 Sep 19;7(9):e2451. doi: 10.1371/journal.pntd.0002451. eCollection 2013. PLoS Negl Trop Dis. 2013. PMID: 24069496 Free PMC article.
-
Humanized monoclonal antibodies derived from chimpanzee Fabs protect against Japanese encephalitis virus in vitro and in vivo.J Virol. 2008 Jul;82(14):7009-21. doi: 10.1128/JVI.00291-08. Epub 2008 May 14. J Virol. 2008. PMID: 18480437 Free PMC article.
-
The Fc region of an antibody impacts the neutralization of West Nile viruses in different maturation states.J Virol. 2013 Dec;87(24):13729-40. doi: 10.1128/JVI.02340-13. Epub 2013 Oct 9. J Virol. 2013. PMID: 24109224 Free PMC article.
-
Isolation of dengue virus-specific memory B cells with live virus antigen from human subjects following natural infection reveals the presence of diverse novel functional groups of antibody clones.J Virol. 2014 Nov;88(21):12233-41. doi: 10.1128/JVI.00247-14. Epub 2014 Aug 6. J Virol. 2014. PMID: 25100837 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases